Featured Partners

Know Diabetes by Heart logo.
American Diabetes Association logo.
Colorectal Cancer Alliance logo.
CardioSmart logo.
National LGBT Cancer Network logo.
Food Outreach logo in green with illustrated basket of whole foods.
Association of Community Cancer Centers logo.
Cancer Support Community logo with a red rising sun icon to the left of black text.
NCODA logo with white text on an orange circle half-outlined in blue.
Anxiety and Depression Association of America logo.
American Psychosocial Oncology Society logo with blue United States icon to the left of black acronym.
Hematology/Oncology Pharmacy Association logo with colorful interlocking square design to the left of gray text.
Circular Community Oncology Alliance logo in red, white, and blue.
Caregiver Action Network logo with blue text and an orange exclamation point with acronym "CAN" in the dot.
Family Reach logo in purple and green with two green swaths on the left.
Compass to Care logo in blue and purple with silhouette of two girls standing together overlaid on a compass shape.
Mercy Medical Angels logo with blue text and medical cross and red icons of a plane, bus, train, and caduceus.
  • By Real World Health Care Editorial Staff  |  Sep 21, 2022

    American Cancer Society Funds Pioneering Research in Acute Lymphoblastic Leukemia

    September is Childhood Cancer Awareness Month, an observance recognized by health care institutions, advocacy organizations, patients and families around the world. While childhood cancer is rare, it is the leading cause of disease-related death past infancy in children and adolescents, according to the National Cancer Institute. Acute Lymphoblastic Leukemia (ALL)…more.

    Categories: CAR-T Cell Therapy, Leukemia
  • By Claire Saxton, Vice President, Education and Outreach, Cancer Support Community  |  Sep 2, 2020

    CAR-T Cell Immunotherapy: What to Expect

    As the largest professionally led nonprofit network of cancer support worldwide, the Cancer Support Community (CSC), including its Gilda’s Club affiliates, is dedicated to ensuring that all people impacted by cancer are empowered by knowledge, strengthened by action, and sustained by community. CSC achieves its mission through three areas: direct…more.

    Categories: CAR-T Cell Therapy, General
  • By Lee Greenberger, PhD, Chief Scientific Officer, The Leukemia & Lymphoma Society  |  Aug 19, 2020

    The Evolution of CAR-T Therapy

    Over the past two decades there’s been tremendous progress in understanding how to harness the body’s immune system to fight cancer. Today, immunotherapy is a mainstay of cancer treatment. One of the most exciting areas of immunotherapy is CAR (chimeric antigen receptor) T-cell therapy. This treatment involves purifying a special…more.

    Categories: CAR-T Cell Therapy, General
  • By Real World Health Care Editorial Staff  |  Aug 5, 2020

    Multiple Myeloma Research Foundation: CAR-T Cell Therapy Initiatives

    Last year, the Multiple Myeloma Research Foundation (MMRF) launched a new, three-year strategic plan to help transform how multiple myeloma is treated and ultimately cured. One of the plan’s three strategic pillars focuses on immunotherapy, including chimeric antigen receptor T-cell (CAR-T) therapy. Real World Health Care spoke with the MMRF’s…more.

    Categories: CAR-T Cell Therapy, General
  • By Real World Health Care Editorial Staff  |  Jul 22, 2020

    CAR T-Cell Therapy Gave Me Back My Life

    Editor’s Note: This week, Real World Health Care shares an inspirational story of a woman who was diagnosed with lymphoma and received treatment with CAR T-cell therapy. “CAR-T Cell Therapy Gave Me My Life Back” is reprinted with permission from the Association of Community Cancer Centers. Updated in April 2020,…more.

    Categories: CAR-T Cell Therapy, General
  • By Real World Health Care Editorial Staff  |  Jun 24, 2020

    Does CAR-T Cell Therapy Belong in Community Clinics?

    CAR T-cell therapy (CAR-T) has emerged as a highly innovative and promising option for patients with cancer. Until recently, the use of CAR-T has been restricted to small clinical trials, primarily with patients with advanced blood cancers. These trials often are conducted at large, academic medical centers in major metropolitan…more.

    Categories: CAR-T Cell Therapy, General
  • By Emily Burke, Ph.D., Director of Instruction, BiotechPrimer.com  |  Mar 11, 2020

    Search & Destroy: Chimeric Antigen Receptor T-Cells (CAR-T)

    Editor’s Note: The following article is reprinted, with permission from Biotech Primer. The original version appeared in the Biotech Primer WEEKLY. To subscribe to the Biotech Primer WEEKLY, click here. The first (and so far, only) chimeric antigen receptor T-cell (CAR-T) therapies—tisagenlecleucel and axicabtagene ciloleucel were approved in 2017, and…more.

    Categories: CAR-T Cell Therapy, General
  • By Krista Zodet, President/CEO, HealthWell Foundation  |  Jan 15, 2020

    Welcoming 2020 with New Insights for Patients with Chronic Diseases

    Topics in Focus: ALS, CAR T Therapies, Macular Degeneration and Movement Disorders The HealthWell Foundation is proud to be a founding sponsor of Real World Health Care. Since 2013, Real World Health Care (RWHC) has brought you compelling content on health care issues facing Americans. From features on the people,…more.

    Categories: Amyotrophic Lateral Sclerosis, CAR-T Cell Therapy, General, Macular Degeneration, Movement Disorders
  • By Shaji Kumar, MD, Professor of Medicine, Hematology, Mayo Clinic  |  Nov 1, 2017

    Multiple Myeloma: Promising New Therapies, But Challenges Remain

    This week, our series on multiple myeloma continues as we talk about immunotherapies and other promising new treatments with Shaji Kumar, MD. Dr. Kumar is a professor of medicine in the division of hematology at Mayo Clinic, where he chairs the myeloma group across all three Mayo sites. Dr. Kumar…more.

    Categories: General, Multiple Myeloma